Sudarshan Chemical Inv. Presentation for Q4 FY26 Results on May 27
Sudarshan Chemical Industries Limited released an investor presentation for Q4 FY26 results on May 27, 2026. The company reported Q4 FY26 consolidated revenue growth of 6.6% YoY and EBITDA growth of 21.6% YoY. For FY26, consolidated revenue increased by 1.7% YoY. The outlook for FY27 projects sales of ~€700 million and EBITDA of ~€35 million.
The announcement provides detailed financial results and future projections, which are material for investors. The progress on integration and strategic outlook indicates potential future growth, impacting investor decisions.
The presentation highlights positive revenue and EBITDA growth for Q4 FY26 and FY26, along with a positive outlook for FY27 and long-term projections for the acquired group. The integration progress and efforts to strengthen the platform also contribute to a positive sentiment.
Sudarshan Chemical Industries Limited has released an investor presentation for their upcoming earnings call on Wednesday, 27th May, 2026, at 10:00 a.m. IST. This presentation covers the Audited Financial Results (Stand-alone and Consolidated) for the quarter and financial year ended 31st March, 2026.
The presentation details the company's performance, including 'One Sudarshan' consolidated results and pigment performance for both Q4 FY26 and the full fiscal year. Key financial highlights for Q4 FY26 include revenue growth of 6.6% YoY and EBITDA growth of 21.6% YoY, with EBITDA margin at 14.4%. For the full year FY26, consolidated revenue grew by 1.7% YoY, and Business EBITDA stood at ₹194 Cr. The company also provided an outlook for FY27, projecting sales of approximately €700 million and EBITDA of around €35 million, with a long-term EBITDA projection of €90-100 million over 3-4 years for the acquired group.
The presentation also touches upon the integration of Sudarshan and Heubach, highlighting progress in SAP integration, the establishment of a Global Capability Center (GCC) in Pune, and the cultivation of a unified 'One Culture'. The company acknowledges past challenges in profitability, working capital, and organizational structure but emphasizes efforts to create a stronger platform for sustainable growth. Financial ratios such as EPS, Adjusted Return on Capital Employed, Net debt to Equity Ratio, and Net working capital as a percentage of sales for FY26 are also provided.
What to do with a filing like this
Sudarshan Chemical Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sudarshan Chemical Industries Limited. Read the original for the full detail.